Open Access
05.09.2022 | Original Research
Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study
Luigi Gargiulo, Luciano Ibba, Giulia Pavia, Carlo Alberto Vignoli, Francesco Piscazzi, Mario Valenti, Federica Sanna, Chiara Perugini, Jessica Avagliano, Antonio Costanzo, Alessandra Narcisi